-65.7%
MRNA vs KEEL
-34.6%
-31.1%
-95.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | KEEL | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +3.8% | +1.6% | +4.8% |
| 7D | -1.1% | +2.9% | -4.0% | -1.6% |
| 30D | +126.1% | +0.8% | +125.3% | +124.7% |
| 3M | +190.0% | -35.3% | +225.4% | +202.0% |
| 6M | +157.2% | +59.4% | +97.9% | +132.7% |
| YTD | +388.2% | +51.9% | +336.3% | +340.0% |
| 1Y | +467.0% | +75.0% | +392.0% | +384.1% |
| 3Y | +36.1% | +224.5% | -188.5% | -6.8% |
| All | -65.7% | -34.6% | -31.1% | -74.0% |
Cumulative growth
Daily Returns
Daily percentage return beside KEEL.
Daily Out/Under-Performance
Portfolio return minus KEEL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × KEEL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded KEEL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling